Literature DB >> 21777245

Expression of the 2',3'-cAMP-adenosine pathway in astrocytes and microglia.

Jonathan D Verrier1, Jennifer L Exo, Travis C Jackson, Jin Ren, Delbert G Gillespie, Raghvendra K Dubey, Patrick M Kochanek, Edwin K Jackson.   

Abstract

Many organs express the extracellular 3',5'-cAMP-adenosine pathway (conversion of extracellular 3',5'-cAMP to 5'-AMP and 5'-AMP to adenosine). Some organs release 2',3'-cAMP (isomer of 3',5'-cAMP) and convert extracellular 2',3'-cAMP to 2'- and 3'-AMP and convert these AMPs to adenosine (extracellular 2',3'-cAMP-adenosine pathway). As astrocytes and microglia are important participants in the response to brain injury and adenosine is an endogenous neuroprotectant, we investigated whether these extracellular cAMP-adenosine pathways exist in these cell types. 2',3'-, 3',5'-cAMP, 5'-, 3'-, and 2'-AMP were incubated with mouse primary astrocytes or primary microglia for 1 h and purine metabolites were measured in the medium by mass spectrometry. There was little evidence of a 3',5'-cAMP-adenosine pathway in either astrocytes or microglia. In contrast, both cell types converted 2',3'-cAMP to 2'- and 3'-AMP (with 2'-AMP being the predominant product). Although both cell types converted 2'- and 3'-AMP to adenosine, microglia were five- and sevenfold, respectively, more efficient than astrocytes in this regard. Inhibitor studies indicated that the conversion of 2',3'-cAMP to 2'-AMP was mediated by a different ecto-enzyme than that involved in the metabolism of 2',3'-cAMP to 3'-AMP and that although CD73 mediates the conversion of 5'-AMP to adenosine, an alternative ecto-enzyme metabolizes 2'- or 3'-AMP to adenosine.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777245      PMCID: PMC3166383          DOI: 10.1111/j.1471-4159.2011.07392.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  49 in total

Review 1.  Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.

Authors:  Trevor W Stone; Stefania Ceruti; Mariapia P Abbracchio
Journal:  Handb Exp Pharmacol       Date:  2009

2.  Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture.

Authors:  P A Rosenberg; M A Dichter
Journal:  J Neurosci       Date:  1989-08       Impact factor: 6.167

3.  Extracellular 3',5'-cAMP-adenosine pathway inhibits glomerular mesangial cell growth.

Authors:  Raghvendra K Dubey; Marinella Rosselli; Delbert G Gillespie; Zaichuan Mi; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2010-03-01       Impact factor: 4.030

4.  Extracellular 2,3-cyclic adenosine monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth [corrected].

Authors:  Edwin K Jackson; Jin Ren; Delbert G Gillespie; Raghvendra K Dubey
Journal:  Hypertension       Date:  2010-06-01       Impact factor: 10.190

5.  Adenosine A1 receptor activation as a brake on the microglial response after experimental traumatic brain injury in mice.

Authors:  M Lee Haselkorn; David K Shellington; Edwin K Jackson; Vincent A Vagni; Keri Janesko-Feldman; Raghvendra K Dubey; Delbert G Gillespie; Dongmei Cheng; Michael J Bell; Larry W Jenkins; Gregg E Homanics; Jurgen Schnermann; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2010-05       Impact factor: 5.269

Review 6.  The extracellular cyclic AMP-adenosine pathway in renal physiology.

Authors:  Edwin K Jackson; Dubey K Raghvendra
Journal:  Annu Rev Physiol       Date:  2004       Impact factor: 19.318

7.  T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response.

Authors:  Michail V Sitkovsky
Journal:  Trends Immunol       Date:  2009-02-07       Impact factor: 16.687

8.  Identification and quantification of 2',3'-cAMP release by the kidney.

Authors:  Jin Ren; Zaichuan Mi; Nicolas A Stewart; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2008-11-25       Impact factor: 4.030

9.  Extracellular 2',3'-cAMP is a source of adenosine.

Authors:  Edwin K Jackson; Jin Ren; Zaichuan Mi
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

Review 10.  Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

Authors:  Michail V Sitkovsky; Dmitriy Lukashev; Sergey Apasov; Hidefumi Kojima; Masahiro Koshiba; Charles Caldwell; Akio Ohta; Manfred Thiel
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  23 in total

Review 1.  The 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

2.  Oxidative stress induces release of 2'-AMP from microglia.

Authors:  Travis C Jackson; Shawn E Kotermanski; Patrick M Kochanek; Edwin K Jackson
Journal:  Brain Res       Date:  2018-11-03       Impact factor: 3.252

3.  Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.

Authors:  Travis C Jackson; Jonathan D Verrier; Tomas Drabek; Keri Janesko-Feldman; Delbert G Gillespie; Thomas Uray; Cameron Dezfulian; Robert S Clark; Hülya Bayir; Edwin K Jackson; Patrick M Kochanek
Journal:  J Pharmacol Exp Ther       Date:  2013-09-10       Impact factor: 4.030

4.  Schwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMP.

Authors:  Jonathan D Verrier; Patrick M Kochanek; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2015-05-21       Impact factor: 4.030

5.  2',3'-cAMP, 3'-AMP, 2'-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors.

Authors:  Elizabeth A Newell; Jennifer L Exo; Jonathan D Verrier; Travis C Jackson; Delbert G Gillespie; Keri Janesko-Feldman; Patrick M Kochanek; Edwin K Jackson
Journal:  Brain Res       Date:  2014-11-03       Impact factor: 3.252

Review 6.  The far-reaching scope of neuroinflammation after traumatic brain injury.

Authors:  Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek
Journal:  Nat Rev Neurol       Date:  2017-02-10       Impact factor: 42.937

7.  The brain in vivo expresses the 2',3'-cAMP-adenosine pathway.

Authors:  Jonathan D Verrier; Travis C Jackson; Rashmi Bansal; Patrick M Kochanek; Ava M Puccio; David O Okonkwo; Edwin K Jackson
Journal:  J Neurochem       Date:  2012-03-20       Impact factor: 5.372

Review 8.  The myelin membrane-associated enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: on a highway to structure and function.

Authors:  Arne Raasakka; Petri Kursula
Journal:  Neurosci Bull       Date:  2014-05-07       Impact factor: 5.203

9.  Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.

Authors:  Edwin K Jackson; Delbert G Gillespie
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-17

Review 10.  Adenosine--a physiological or pathophysiological agent?

Authors:  Bertil B Fredholm
Journal:  J Mol Med (Berl)       Date:  2013-12-22       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.